NHS lands breakthrough in global battle against superbugs

  17 June 2022

The NHS is set to roll out two ‘superbug’ busting drugs through a world-first, pioneering subscription deal that will help tackle antimicrobial resistance, the head of the NHS announced today.

The deal, initially for two antimicrobial drugs, means patients with serious infections that have evolved so much that antibiotics and other current treatments are no longer effective, can be given a potentially life-saving alternative.

These drugs will provide a lifeline to patients with life-threatening infections like sepsis, hospital or ventilator pneumonia and blood stream infection, with increasing numbers of people developing drug resistance as germs evolve to become resistant to current antibiotics.


Further reading: NHS
Author(s): NHS
Smart Innovations  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!